Anti-convulsive therapy in old age - Principles and differential aspects of treatment;Antikonvulsive behandlung im hoheren lebensalter - Grundlagen und differentialindikation

Fortschritte der Neurologie Psychiatrie

Volumn 65, Issue 6, 1997, Pages 261-277

  Hetzel, W ^a  

^a Neurologische Abteilung   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

AGED; ARTICLE; COGNITIVE DEFECT; CONVULSION; DRUG EFFECT; DRUG INDUCED DISEASE; ELDERLY CARE; HEART ARRHYTHMIA; HUMAN; EPILEPSY; PSYCHOLOGICAL ASPECT; REVIEW;

AGED; ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 0031160241     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996331     Document Type: Article

References (148)

1. Aitken, M. L, T. R. Martin: Life-threatening theophylline toxicity is not predictable by serum levels. Chest 91 (1987) 10 - 14
2. Aldenkamp, A. P. et al.: Withdrawal of antiepileptic medication in children - effects on cognitive function: The multicenter Holmfrid study. Neurology 43 (1993) 41 - 50
3. Annegers, J. F., S. B. Shirts, W. A. Hauser, L. T. Kurland: Risk of recurrence after an initial unprovoced seizure. Epilepsia 27 (1986) 43 - 50
4. Arieff, A. I.: Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. NEJM 314 (1986) 1529 - 1535
5. Baruzzi, A., G. Procaccianti, P. Martinelli, R. Riva, F. Denoth, N. Montanaro, E. Lugaresi: Phenobarbital and Propranolol in essential tremor: A double-blind controlled clinical trial. Neurology 33 (1983) 296 - 300
6. Bahls, F. H., K. K. Ma, Th. D. Bird: Theophyllin-associated seizures with "therapeutic" or low toxic serum concentrations: Risk factors for serious outcome in adults. Neurology 41 (1991) 1309
7. Bauer, J., C. E. Elger: Die akute Valproinsäure-Enzephalopathie. Akt. Neurol. 20 (1993) 16 - 21
8. Bauer, L. A.: Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology 32 (1982) 570 - 572
9. Beermann, B., O. Edhag, H. Vallin: Advanced heart block aggravated by carbamazepine. British Heart Journal 37 (1975) 668
10. Benassi, E., G. P. Bo, L. Cocito, M. Maffini, C. Loeb: Carbamazepine and cardiac conduction disturbances. Annals of Neurology 22 (1987) 280 - 281
11. Berlit, P.: Die zentrale pontine Myelinolyse. Nervenarzt 57 (1986) 624 - 633
12. 11 aBittencourt, P. R. M., C. M. Garcia, R. Martins, A. G. Fernandes, H. W. Diekmann, W. Jung: Phenytoin and carbamazepine decrease oral bioavailability of praziquantel. Neurology 42 (1992) 492
13. Biton, V., J. R. Gates, L. Sussmann: Prolonged postictal encephalopathy. Neurology 40 (1990) 963 - 966
14. Bivins, B. A., R. P. Rapp, W. O. Griffen, R. Blouin, J. Bustrack: Dopamine - phenytoin interaction. A cause of hypotension in the critically ill. Archives of Surgery 113 (1978) 245 - 249
15. Blank, R.: Antikonvulsiva und ihre psychischen Wirkungen - eine Übersicht. Fortschr. Neurol. Psychiat. 58 (1990) 19 - 32
16. Boesen, F., E. B. Andersen, E. K. Jensen, S. D. Ladefoget: Cardiac conduction disturbances during carbamazepine therapy. Acta Neurol. Scand. 68 (1983) 49 - 52
17. Brodie, M. J., M. A. Dichter: Antiepileptic drugs. NEJM 334 (1996) 168 - 175
18. Bruni, J., P. Albright: Valproic acid therapy for complex partial seizures. Arch. Neurol. 40 (1983) 135 - 137
19. Bryson, S. M., N. Verma, P. J. W. Scott, P. C. Rubin: Pharmacokinetics of valproic acid in young and elderly subjects. Br. J. Clin. Pharmac. 16 (1983) 104 - 105
20. Callaghan, N., R. A. Kenny, B. O'Neill, M. Crowley, T. Goggin: A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 48 (1985) 639 - 644
21. Cascino, G. D.: Nonconvulsive status epilepticus in adults and children. Epilepsia 34, suppl 1 (1993) S21 - S28
22. Cloyd, J.: Pharmacokinetic pitfalls of present antiepileptic medications. Epilepsia 32, suppl 5 (1991) S53-S65
23. Greenblatt, D. J., R. I. Shader: Intravenous phenytoin (letter). NEJM 295 (1976) 1078
24. Cranford, R. E., I. E. Leppik, B. Patrick, Ch. B. Anderson, B. Kostick: Intravenous phenytoin: clinical and pharmacokinetic aspects. Neurology 28 (1978) 874 - 880
25. Dam, M.: Side-effects of drug treatment in epilepsy. Acta Neurol. Scand. 78, suppl 117 (1988) 34 - 41
26. Dam, M., L. Gram (eds.): Comprehensive Epileptology. Raven Press, New York 1991
27. DeLorenzo, R. J., A. R. Towne, J. M. Pellock, D. Ko: Status epilepticus in children, adults, and the elderly. Epilepsia 33, suppl 4 (1992) S15 - S25
28. Devinsky, O.: Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 36, suppl 2 (1995) S46 - S65
29. Dodrill, C. B., A. S. Troupin: Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin. Neurology 27 (1977) 1023 - 1028
30. Dodrill, C. B., N. R. Temkin: Motor speed is a contaminating factor in evaluating the "cognitive" effects of phenytoin. Epilepsia 30 (1989) 453 - 457
31. Dodrill, C. B., A. S. Troupin: Neuropsychological effects of carbamazepine and phenytoin: A reanalysis. Neurology 41 (1991) 141
32. Dodson, W. E.: Level off. Neurology 39 (1989) 1009 - 1010
33. Drake, M. E., C. E. Coffey: Complex partial status simulating psychogenic unresponsiveness. Am. J. Psychiatry 140 (1983) 800
34. Drury, I., D. W. Klass, B. F. Westmoreland, F. W. Sharbrough: An acute syndrome with psychiatric symptoms and EEG abnormalities. Neurology 35 (1985) 911 - 914
35. Durelli, L., R. Mutani, G. P. Sechi, F. Monaco, N. Glorioso, G. Gusmaroli: Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon? Archives of Neurology 42 (1985) 1067 - 1068
36. Earnest, M. P., J. A. Marx, L. R. Drury: Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage. JAMA 249 (1983) 762 - 765
37. Engel, J., B. I. Ludwig, M. Fetell: Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology 28 (1978) 863 - 869
38. Evens, R. P., D. G. Fraser, T. M. Ludden, E. W. Sutherland: Phenytoin toxicity and blood levels after a large oral dose. American Journal of Hospital Pharmacy 37 (1980) 232 - 235
39. Flegel, K. M., C. H. Cole: Inappropriate antidiuresis during carbamazepine treatment. Annals of Internal Medicine 87 (1977) 722 - 723
40. Forsythe, I., R. Butler, I. Berg, R. McGuire: Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine. phenytoin and sodium valproate. Dev. Med. Child. Neurol. 33 (1991) 524 - 534
41. Gänshirt, H., G. Haack: Oligoepilepsien des mittleren und höheren Lebensalters. Eine besondere Verlaufsform idiopathischer Epilepsien. Nervenarzt 54 (1983) 628 - 632
42. Galassi, R., A. Morreale, S. Lorusso, C. Procaccianti, E. Lugaresi, A. Baruzzi: Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal. Archives of Neurology 45 (1988) 892 - 894
43. Gandelman, M. S.: Review of carbamazepine-induced hyponatremia. Progress in Neuro-Psychopharmakology and Biological Psychiatry 18 (1994) 211 - 233
44. Gasparetti, C. M.: Conduction abnormalities complicating carbamazepine therapy (letter). Am. J. Med. 82 (1987) 381
45. Gershon, C. N., G. Lantos, W. B. Barr, N. Schaul: Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Archives of Neurology 51 (1994) 767 - 771
46. Ghatak, N. R., R. A. Santoso, W. M. McKinney: Cerebellar degeneration following long-term phenytoin therapy. Neurology 26 (1976) 818 - 820
47. Godfrey, J. W., M. A. Roberts, F. I. Caird: Epileptic seizures in the elderly: II. Diagnostic problems. Age and Ageing 11 (1982) 29
48. Gorman, W. P., R. Cooper, P. Pocock, M. J. Campbell: A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis. J. Neurol. Neurosurg. Psychiatry 49 (1986) 64 - 68
49. Goulden, K. J., J. M. Dooley, P. R. Camfield, A. D. Fraser: Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 37 (1987) 1392 - 1394
50. Craig, I., R. Tallis: Impact of valproate and phenytoin on cognitive function in elderly patients: Results of a single-blind randomized comparative study. Epilepsia 35 (1994) 381 - 390
51. Gram, L.: Valproate: In: Dam, M., L. Gram (eds.): Comprehensive Epileptology. Raven Press, New York (1991) 537 - 546
52. Granner, M. A., S. I. Lee: Nonconvulsive status epilepticus: EEG analysis in a large series. Epilepsia 35 (1994) 42 - 47
53. Greenblatt, D. J., E. M. Sellers, R. I. Shader: Drug disposition in old age. NEJM 306 (1982) 1081 - 1088
54. Hart, Y. M., J. W. A. S. Sander, A. L. Johnson, S. D. Shorvon: National General Practice Study of Epilepsy: Recurrence after a first seizure. Lancet 336 (1990) 1271 - 1274
55. Hauser, W. A., V. E. Anderson, R. P. Loewenson, S. M. McRoberts: Seizure recurrence after a first unprovoked seizure. NEJM 307 (1982) 522 - 528
56. Hauser, W. A.: Seizure disorders: The changes with age. Epilepsia 33, suppl 4 (1992) S6 - S14
57. Hayes, M. J., M. J. S. Langman, A. H. Short: Metabolism with increasing age: 2. Phenytoin clearance and protein binding. Br. J. Clin. Pharmacol. 2 (1975) 73 - 79
58. Heller, A. J., P. Chesterman, R. D. C. Elwes, P. Crawford, D. Chadwick, A. L. Johnson, E. H. Reynolds: Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: A randomized comparative monotherapy trial. J. Neurol. Neurosurg. Psychiatry 58 (1995) 44 - 50
59. Helmchen, Ch., B. J. Steinhoff, M. Dichgans: Varianten der Toddschen Parese: Postiktuale Apraxie und prolongierter postiktualer Hemineglect. Nervenarzt 65 (1994) 700 - 703
60. Hendeles, L.: Theophylline and seizures (letter). Neurology 42 (1992) 2054
61. Herzberg, L.: Carbamazepine and bradycardia (letter). Lancet 311 (1978 I) 1097 - 1098
62. Hetzel, W.: Carbamazepin - Mittel der ersten Wahl bei älteren Patienten? In: Reichert, K. (Hrsg.): Aspekte neurologischer Rehabilitation. Kliniken für Rehabilitation, Waldbronn, Dobel (1995) 49 - 65
63. Hewetson, K. A., A. E. S. Ritch, R. D. S. Watson: Sick sinus syndrom aggravated by carbamazepine therapy for epilepsy. Postgraduate Medical Journal 62 (1986) 497 - 498
64. Hildick-Smith, M.: Epilepsy in the elderly. Age and Ageing 3 (1974) 203 - 208
65. Hyman, N. M., P. D. Dennis, K. G. A. Sinclair: Tremor due to sodium valproate. Neurology 29 (1979) 1177 - 1180
66. Inoue, H., K. Takayanagi, K. Ueda, J. Mifune, S. Ohkawa, M. Sugiura: Three cases of sinuatrial block induced by anticonvulsants. Japanese Heart Journal 19 (1978) 544 - 551
67. Jamal, G. A., C. J. Fowler, K. Leslie, P. F. Prior, J. Gawler: Non-convulsive status epilepticus as a cause of acute confusional state in the 60-over age group. J. Neurol. Neurosurg. Psychiatry 51 (1988) 738
68. Johannesen, A. C., O. A. Nielsen: Hyponatremia induced by oxcarbazepine. Epilepsy Research 1 (1987) 155 - 156
69. Juergens, S. M., D. S. Milliner, M. E. Lee: Carbamazepine and hyponatremia. Am. J. Psychiatry 143 (1986) 1328 - 1329
70. Juergens, S. M., D. S. Milliner, M. E. Lee: Carbamazepine and hyponatremia. Am. J. Psychiatry 143 (1986) 1328 - 1329
71. Karas, B. J., B. J. Wilder, E. J. Hammond, A. W. Bauman: Valproate tremors. Neurology 32 (1982) 428 - 432
72. Karas, B. J., B. J. Wilder, E. J. Hammond, A. W. Bauman: Treatment of valproate tremors. Neurology 33 (1983) 1380 - 1382
73. Kasarskis, E. J., Ch. S. Kuo, R. Berger, K. R. Nelson: Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndroms. Arch. Intern. Med. 152 (1992) 186 - 191
74. Kennebäck, G., L. Bergfeldt, H. Vallin, T. Tomson, O. Edhag: Electrophysiologic effects and clinical hazards of Carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. American Heart Journal 121 (1991) 1421 - 1429
75. Kennebäck, G., L. Bergfeldt, T. Tomson, E. Spina, O. Edhag: Carbamazepine-induced bradycardia - a problem in general or only in susceptible patients? A 24-h long-term electrocardiogram study. Epilepsy Research 13 (1992) 141 - 145
76. Kenny, R. A., G. Traynor: Carotid sinus syndrome - clinical characteristics in elderly patients. Age and Ageing 20 (1991) 449
77. Kick, H., H. P. Haack: EEG-Muster eines Status psychomotoricus und schizophrenes Syndrom. Nervenarzt 53 (1982) 401 - 405
78. Knight, R. T., J. Cooper: Status epilepticus manifesting as reversible Wernicke's aphasia. Epilepsia 27 (1986) 301 - 304
79. Koivikko, M. J., S. L. Valikangas: Hyponatremia during Carbamazepine therapy in children. Neuropediatrics 14 (1983) 93 - 96
80. Krämer, G.: Stellenwert der Plasmaspiegelbestimmung von Antiepileptika. Fortschr. Neurol. Psychiat 57 (1989) 411 - 424
81. 78aKrämer, G., R. Besser, M. Theisson: Interaktionen von Carbamazepin mit anderen Medikamenten. In: Krämer, G., H. C. Hopf (Hrsg.): Carbamazepin in der Neurologie. Thieme Verlag, Stuttgart : New York (1987) 70 - 90
82. Krämer, G.: Posttraumatische Anfälle und Epilepsien. Epilepsie-Blätter 8 (1995) 12 - 17
83. Krueger, K. A., W. A. Garnett, T. I. Comstock, W. E. Fitzsimmons, H. T. Karnes, J. M. Pellock: Effect of two administration schedules of an enterai nutrient formula on phenytoin bioavailability. Epilepsia 28 (1987) 706 - 712
84. Kutt, H.: Hydantoins. In: Dam, M., L. Gram (eds.): Comprehensive Epileptology. Raven Press, New York (1991) 563 - 577
85. Labreque, J., M. A. Coté, P. Vincent: Carbamazepine-induced atrioventricular block. Am. J. Psychiatry 149 (1992) 572 - 573
86. Ladefoget, S. D., J. C. Mogelvang: Total atrioventricular block with syncopes complicating Carbamazepine therapy. Acta. Med. Scand. 212 (1982) 185 - 186
87. Lee, S. I.: Nonconvulsive status epilepticus. Ictal confusion in later life. Arch. Neurol. 42 (1985) 778 - 781
88. Lennox, W. G.: Brain injury, drugs, and environment as causes of mental decay in epilepsy. Am. J. Psychiatry 99 (1942) 174
89. Leppik, I. E.: Carbamazepine. In: Dam, M., L. Gram (eds.): Comprehensive Epileptology. Raven Press, New York (1991) 525
90. Leppik, I. E.: Metabolism of antiepileptic medication: Newborn to elderly. Epilepsia 33, suppl 4 (1992) S32 - S40
91. Levy, R. H.: Cytochrome P450 isoencymes and antiepileptic drug interactions. Epilepsia 36, suppl 5 (1995) S8 - S13
92. Loisean, P., B. Duche: Phenobarbital. In: Dam, M., L. Gram (eds.): Comprehensive Epileptology. Raven Press, New York (1991) 579
93. Lühdorf, K., L. K. Jensen, A. M. Plesner: Epilepsy in the elderly: Incidence, social function, and disability. Epilepsia 27 (1986) 135 - 141
94. Luhdorf, K., L. K. Jensen, A. M. Plesner: Etiology of seizures in the elderly. Epilepsia 27 (1986) 458 - 463
95. Mamoli, B., J. Spatt, W. Pankl: Zur Therapie der Altersepilepsie. Wien. Klin. Wochenschr. 105 (1993) 453 - 458
96. Mattson, R. H., J. A. Cramer: Primidone. In: Dam, M., L. Gram (eds.): Comprehensive epileptology. Raven Press, New York (1991) 592 - 601
97. Mattson, R. H., J. A. Cramer, J. F. Collins et al.: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. NEJM 327 (1992) 765 - 771
98. Meador, K. J., D. W. Loring, K. Huh, B. B. Gallagher, D. W. King: Comparative cognitive effects of anticonvulsants. Neurology 40 (1990) 391 - 394
99. Meador, K. J., D. W. Loring, L. L. Abney, M. E. Allen, E. E. Moore, E. Y. Zamrini, D. W. King: Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34 (1993) 153 - 157
100. Mumenthaler, M. (Hrsg.): Synkopen und Sturzanfälle. Thieme Verlag, Stuttgart : New York 1984
101. Nechwatal, R., N. Skiba, H. Lutz: Zentrale pontine Myelinolyse bei zwei Patienten nach Therapie einer schweren Hyponatriämie. Medizinische Klinik 88 (1993) 72 - 77
102. Nielsen, O. A., A. C. Johannessen, B. Bardrum: Oxcarbazepine-induced hyponatremia, a cross-sectional study. Epilepsy Research 2 (1988) 269 - 271
103. O'Dougherty, M., F. S. Wright, S. Cox, Ph. Walson: Carbamazepine plasma concentration. Relationship to cognitive impairment. Arch. Neurol. 44 (1987) 863 - 867
104. O'Hagan, M., S. J. Wallace: Enterai formula feeds interfere with phenytoin absorption. Brain and Development 16 (1994) 165
105. Patsalos, P. N., J. S. Duncan: Antiepileptic drugs. A review of clinically significant drug interactions. Drug Safety 9 (1993) 156
106. Perucca, E., I. Hebdige, G. M. Frigo, G. Gatti, S. Lecchini, A. Crema: Interaction between phenytoin and valproic acid: Plasma protein binding and metabolic effect. Clin. Pharmacol. Ther. 28 (1980) 779 - 789
107. Perucca, E., R. Grimaldi, G. Gatti, S. Pirracchio, F. Crema, G. M. Frigo: Pharmacokinetics of valproic acid in the elderly. Br. J. Clin. Pharmacol. 17 (1984) 665 - 667
108. Platt, D.: Physiologische Altersveränderungen und ihre Bedeutung für die Arzneimitteltherapie. Deutsches Ärzteblatt 92 (1995) 37 - 40
109. Pohlmann-Eden, B., A. Schreiner, A. Mika: Diagnostische und prognostische Implikationen des ersten epileptischen Anfalls im Erwachsenenalter. Fortschr. Neurol. Psychiat. 62 (1994) 147
110. Puletti, M., C. Iani, M. Curione, M. Trappolini, M. Manfredi: Carbamazepine and the heart. Ann. Neurol. 29 (1991) 575 - 576
111. Rambeck, B., G. Krämer: Medikamentöse Interaktionen von und mit Valproinsäure. In: Krämer, G., M. C. Laub (Hrsg.): Valproinsäure. Springer Verlag, Berlin, Heidelberg (1992) 106 - 112
112. Randazzo, D. N., A. Ciccone, P. Schweitzer, S. L. Winters: Complete atrioventricular block with ventricular asystole following infusion of intravenous phenytoin. Journal of Electrocardiology 28 (1995) 157 - 159
113. Richens, A., D. L. W. Davidson, N. E. F. Cartlidge, D. J. Easter et al.: A multicentre comparative trial of sodium valproat and carbamazepine in adult onset epilepsy. J. Neurol. Neurosurg. Psychiatry 57 (1994) 682 - 687
114. 110aRiva, R., A. Cerullo, F. Albani, A. Baruzzi: Ticlopidine impairs phenytoin clearance: A case report. Neurology 46 (1996) 1172
115. Sander, J. W. A. S., Y. M. Hart, A. L. Johnson, S. D. Shorvon et al.: National General Practice Study of Epilepsy: Newly diagnosed epileptic seizures in a general population. Lancet 336 (1990) 1267 - 1271
116. Schönbeck, S., D. Schwarz, G. Kurtz: Komplex-fokale Anfälle als Ursache einer mehrjährigen paranoiden Psychose des höheren Lebensalters. Nervenarzt 64 (1993) 814 - 816
117. Schumm, F.: Altersepilepsie unter besonderer Berücksichtigung der Therapie. In: Fröscher, W. (Hrsg.): Aspekte der Epilepsie-Therapie. Ueberreuther Wissenschaft, Wien, Berlin (1989) 27
118. Scollo-Lavizzari, G., Ch. Kätterer, R. Kocher: Epilepsien des mittleren und höheren Lebensalters. Schweiz. Rundschau Med, 81 (1992) 1500 - 1503
119. Selhorst, J. B., B. Kaufman, S. J. Horwitz: Diphenylhydantoin-induced cerebellar degeneration. Arch. Neurol. 27 (1972) 453
120. Shinton, R. A., J. S. Gill, A. V. Zezulka, D. G. Beevers: The frequency of epilepsy preceeding stroke. Case-control study in 230 patients. Lancet I (1987) 11 - 13
121. Smith, D. B., R. H. Mattson, J. A. Cramer, J. F. Collins, R. A. Novelly, B. Craft et al.: Results of an nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 28, suppl 3 (1987) S50 - S58
122. Smith, K. R., P. M. Goulding, D. Wilderman, P. G. Goldfader, P. Holterman-Hommes: Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: A comparative study. Arch. Neurol. 51 (1994) 653 - 660
123. Sordillo, P., D. M. Sagransky, R. Mercado, M. F. Michelis: Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion. Arch. Intern. Med. 138 (1978) 299 - 301
124. Stefan, H.: Epilepsien. Diagnose und Behandlung. 2. Aufl. Chapman u. Hall, Weinheim 1995
125. Steinhoff, B. J., K. D. Stoll, S. R. Stodieck, W. Paulus: Hyponatremic coma under oxcarbazepine therapy. Epilepsy Research 11 (1992) 67 - 70
126. Steinhoff, B. J., B. Neumann: Die Carbamazepin-Enzephalopathie - eine seltene Nebenwirkung. Akt. Neurol. 21 (1994) 191
127. Stephens, W. P., M. L. E. Espir, R. B. Tattersall: Water intoxication due to carbamazepine. British Medical Journal I (1977) 754
128. Sterns, R. H., J. E. Riggs, S. S. Schochet: Osmotic demyelination syndrome following correction of hyponatremia. NEJM 314 (1986) 1535 - 1542
129. Takayanagi, K., H. Yamaguchi, T. Hayashi, S. Morooka, Y. Takabatake: Carbamazepine-induced bradycardia-tachycardia syndrome with pharmacological analysis and concurrent ECG monitoring. Journal of Electrocardiology 23 (1990) 85 - 88
130. Tallis, R.: Epilepsy in old age. Lancet 336 (1990) 295 - 296
131. Tallis, R., G. Hall, I. Craig, A. Dean: How common are epileptic seizures in old age? Age and Ageing 20 (1991) 442 - 448
132. Terzano, M. G., L. Parrino, A. Mazzucchi, G. Moretti: Confusional states with Periodic Lateralized Epileptiform Discharges (PLEDs): A peculiar epileptic syndrome in the elderly. Epilepsia 27 (1986) 446 - 457
133. Todd, R. B.: Clinical lectures on paralysis, diseases of the brain, and other affections of the nervous system. London (1854) 281
134. Tomson, T., U. Lindbom, B. Y. Nilsson: Nonconvulsive status epilepticus in adults: Thirty-two consecutive patients from a general hospital population. Epilepsia 33 (1992) 829 - 835
135. Trimble, M. R., P. J. Thompson: Sodium valproate and cognitive function. Epilepsia 25, suppl 1 (1984) S60-S64
136. Trimble, M. R., C. A. Cull, P. J. Thompson: Anticonvulsant drugs and cognitive function: An update. In: Dam, M. et al. (eds.): Epilepsy: Progress in Treatment. John Wiley and Sons Ltd. (1987) 137 - 149
137. Turnbull, D. M., M. D. Rawlins, D. Weightman, D. W. Chadwick: A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J. Neurol. Neurosurg. Psychiatry 45 (1982) 55 - 59
138. Turnbull, D. M., D. Howel, M. D. Rawlins, D. W. Chadwick: Which drug for the adult epileptic patient: phenytoin or valproate? British Medical Journal 290 (1985) 815 - 819
139. Uziel, Y., A. Pomeranz, R. Jedeikin, B. Wolach: Acute carbamazepine poisoning and hyponatremia. Child Nephrology and Urology 9 (1988 - 89) 87 - 89
140. Vahar-Matiar, M., W. Fröscher: Die Osteopathia antiepileptica bei Jugendlichen und Erwachsenen. Fortschr. Neurol. Psychiat. 56 (1988) 207 - 240
141. Van Amselsvoort, Th., R. Bakshi, C. B. Devaux, S. Schwabe: Hyponatremia associated with carbamazepine and oxcarbazepine therapy: A review. Epilepsia 35 (1994) 181 - 188
142. Van der Meyden, C. H., A. J. Kruger, F. O. Müller, W. Rabie, R. Schall: Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Epilepsia 35 (1994) 189 - 194
143. Willmore, L. J.: The effect of age on pharmacokinetics of antiepileptic drugs. Epilepsia 36, suppl 5 (1995) S14 - S21
144. Wolf, P.: Antiepileptika haben keinen therapeutischen Bereich. Dtsch. med. Wschr. 116 (1991) 631 - 633
145. Yassa, R., C. Nastase, Y. Camille, M. Henderson, L. Belzile, F. Beland: Carbamazepine, diuretics, and hyponatremia: A possible interaction. Journal of Clinical Psychiatry 48 (1987) 281 - 283
146. York, R. C., S. T. Coleridge: Cardiopulmonary arrest following intravenous phenytoin loading. American Journal of Emergency Medicine 6 (1988) 255 - 259
147. Zaret, B. S., R. A. Cohen: Reversible valproic acid-induced dementia: A case report. Epilepsia 27 (1986) 234 - 240
148. Zoneraich, S., O. Zoneraich, J. Siegel: Sudden death following intravenous diphenylhydantoin. American Heart Journal 91 (1976) 375 - 377